Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 (‘Telomelysin-RGD’)
Open accessAbstract
Replication-competent oncolytic viruses are being developed for human cancer therapy. We previously reported that an attenuated adenovirus (OBP-301, 'Telomelysin'), in which the hTERT promoter element drives expression of E1A and E1B genes linked with an IRES, could replicate in cancer cells, and causes selective lysis of cancer cells. We further constructed OBP-405 ('Telomelysin-RGD') that contains an RGD motif in the HI loop of the fiber knob. We examined whether OBP-405 could be effective in overcoming the limitations of OBP-301, specifically their inefficient infection into cells lacking the primary receptor, the coxsackievirus and adenovirus receptor (CAR). By flow cytometric analysis, H1299 (lung) and SW620 (colorectal) tumor cells showed high levels of CAR expression, whereas LN444 (glioblastoma), LNZ308 (glioblastoma), and H1299-R5 (lung) tumor cells were negative for CAR expression. A quantitative real-time PCR analysis demonstrated that fiber-modified OBP-405 infected more efficiently than OBP-301, although the intracellular replication rate of both viruses was consistent. The comparative antitumor effect of fiber-modified OBP-405 and unmodified OBP-301 for human cancer cells was evaluated in vitro by XTT assay as well as in vivo by using athymic mice carrying xenografts. OBP-405 had a profound oncolytic effect on human cancer cell lines compared to OBP-301, in particular on cells with low CAR expression. Intratumoral injection of 10(7) plaque-forming units of OBP-405 into CAR-negative H1299-R5 lung tumor xenografts in nu/nu mice resulted in a significant inhibition of tumor growth and long-term survival in all treated mice. Moreover, selective replication of OBP-405 in the distant, uninjected H1299-R5 tumors was demonstrated. Our results suggest that fiber-modified replication-competent adenovirus OBP-405 exhibits a broad target range by increasing infection efficiency, an outcome that has important implications for the treatment of human cancers.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Telomelysin efficiently kills a broad range of cancer cell types, including head and neck, lung, esophageal, pancreatic, hepatic, prostate, cervical cancers, melanoma, sarcoma, and mesothelioma.
“Indeed, Telomelysin could efficiently kill head and neck, lung, esophageal, pancreatic, hepatic, prostate, and cervical cancers, as well as melanoma, sarcoma, and mesothelioma cells.(106,110)”
From Understanding and exploiting <i>hTERT</i> promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [110]
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 2× · see citing works
“In fact, many studies have reported that telomerase is present in nearly all immortal cell lines and B90% of human tumors but seldom in normal somatic cells (Kim et al., 1994; Shay and Wright, 1996).”
BackgroundIdentification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · see citing works
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt‐Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102 · see citing works
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256 · see citing works
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199 · see citing works
Tomko, R. P., Xu, R., & Philipson, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3352 · Cited by 1,200 · see citing works
The polypeptides of adenovirus
Maizel, J. V., WHITE, D. O., & Scharff, M. D. (1968) · Virology · doi:10.1016/0042-6822(68)90121-9 · Cited by 883 · see citing works
Dmitriev, I. P., Krasnykh, V. N., Miller, C. R., Wang, M., Kashentseva, E. A., Mikheeva, G., Belousova, N., & Curiel, D. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9706-9713.1998 · Cited by 768 · see citing works
Telomerase in the human organism
Collins, K., & Mitchell, J. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205083 · Cited by 600 · see citing works
Kirn, D. H., Martuza, R. L., & Zwiebel, J. A. (2001) · Nature Medicine · doi:10.1038/89901 · Cited by 505 · see citing works
Wickham, T. J., Tzeng, E., Shears, L. L., Roelvink, P. W., Li, Y., Lee, G. M., Brough, D. E., Lizonová, A., & Kovesdi, I. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8221-8229.1997 · Cited by 487 · see citing works
A SIMPLE AND EFFICIENT METHOD FOR PURIFICATION OF INFECTIOUS RECOMBINANT ADENOVIRUS
Kanegae, Y., Makimura, M., & Saito, I. (1994) · Japanese Journal of Medical Science and Biology · doi:10.7883/yoken1952.47.157 · Cited by 444 · see citing works
Telomerase activity in human cancer
Shay, J. W., & Wright, W. E. (1996) · Current Opinion in Oncology · doi:10.1097/00001622-199601000-00012 · Cited by 404 · see citing works
A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.
Ginsberg, H. S., Moldawer, L. L., Sehgal, P. B., Redington, M., Kilian, P. L., Chanock, R. M., & Prince, G. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1651 · Cited by 353 · see citing works
Cancer gene therapy: fringe or cutting edge?
McCormick, F. P. (2001) · Nature reviews. Cancer · doi:10.1038/35101008 · Cited by 345 · see citing works
Krasnykh, V. N., Dmitriev, I. P., Mikheeva, G., Miller, C. R., Belousova, N., & Curiel, D. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1844-1852.1998 · Cited by 314 · see citing works
Telomerase-Specific Replication-Selective Virotherapy for Human Cancer
Kawashima, T., Kagawa, S., Kobayashi, N., Shirakiya, Y., Umeoka, T., Teraishi, F., Taki, M., Kyo, S., Tanaka, N., & Fujiwara, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1075-3 · Cited by 262 · see citing works
Self-citationMizuguchi, H., Koizumi, N., Hosono, T., Utoguchi, N., Watanabe, Y., Kay, M. A., & Hayakawa, T. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301453 · Cited by 225 · see citing works
Self-citationPathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus)
Prince, G. A., Porter, D. D., Jenson, A. B., Horswood, R. L., Chanock, R. M., & Ginsberg, H. S. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.101-111.1993 · Cited by 177 · see citing works
Wood, M. L., Perrotte, P., Onishi, E., Harper, M., Dinney, C. P., Pagliaro, L. C., & Wilson, D. R. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700090 · Cited by 127 · see citing works
Koga, S., Hirohata, S., Kondo, Y., Komata, T., Takakura, M., Inoue, M., Kyo, S., & Kondo, S. (2000) · Human Gene Therapy · doi:10.1089/10430340050057477 · Cited by 112 · see citing works
Self-citationFechner, H., Wang, X., Wang, H., Jansen, A., Pauschinger, M., Scherübl, H., Bergelson, J. M., Schultheiss, H.-P., & Poller, W. C. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301321 · Cited by 85 · see citing works
Davydova, J., Le, L. P., Gavrikova, T. A., Wang, M., Krasnykh, V. N., & Yamamoto, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0064 · Cited by 77 · see citing works
Umeoka, T., Kawashima, T., Kagawa, S., Teraishi, F., Taki, M., Nishizaki, M., Kyo, S., Nagai, K., Urata, Y., Tanaka, N., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1335 · Cited by 72 · see citing works
Self-citationGu, J. H., Zhang, L., Huang, X., Lin, T.-Y., Yin, M., Xu, K., Ji, L., Roth, J. A., & Fang, B. (2002) · Oncogene · doi:10.1038/sj.onc.1205582 · Cited by 47 · see citing works
Molecular therapeutics: promise and challenges
Kohn, E. C., Lu, Y., Wang, H., Yu, Q., Yu, S., Hall, H. S., Smith, D. L., Meric‐Bernstam, F., Hortobágyi, G. N., & Mills, G. B. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.01.009 · Cited by 24 · see citing works
Tango, Y., Taki, M., Shirakiya, Y., Ohtani, S., Tokunaga, N., Tsunemitsu, Y., Kagawa, S., Tani, T., Tanaka, N., & Fujiwara, T. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03232.x · Cited by 18 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Kyo, S., Takakura, M., Fujiwara, T., & Inoue, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00878.x · Cited by 347 · see citing works
Self-citationNemunaitis, J. J., Tong, A. W., Nemunaitis, M., Senzer, N. N., Phadke, A. P., Bedell, C., Adams, N., Zhang, Y.-A., Maples, P. B., Chen, S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.262 · Cited by 266 · see citing works
Self-citationIn vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus
Kishimoto, H., Kojima, T., Watanabe, Y., Kagawa, S., Fujiwara, T., Uno, F., Teraishi, F., Kyo, S., Mizuguchi, H., Hashimoto, Y., et al. (2006) · Nature Medicine · doi:10.1038/nm1404 · Cited by 179 · see citing works
Self-citationAutophagic Cell Death of Malignant Glioma Cells Induced by a Conditionally Replicating Adenovirus
Ito, H., Aoki, H., Kühnel, F., Kondo, Y., Kubicka, S., Wirth, T. C., Iwado, E., Iwamaru, A., Fujiwara, K., Hess, K. R., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj161 · Cited by 176 · see citing works
Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis
Dorer, D. E., & Nettelbeck, D. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.013 · Cited by 150 · see citing works
Kishimoto, H., Zhao, M. D., Hayashi, K., Urata, Y., Tanaka, N., Fujiwara, T., Penman, S., & Hoffman, R. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906388106 · Cited by 141 · see citing works
Self-citationA simple biological imaging system for detecting viable human circulating tumor cells
Kojima, T., Hashimoto, Y., Watanabe, Y., Kagawa, S., Uno, F., Kuroda, S., Tazawa, H., Kyo, S., Mizuguchi, H., Urata, Y., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38609 · Cited by 116 · see citing works
Self-citationPesonen, S. A., Diaconu, I., Cerullo, V., Escutenaire, S., Raki, M., Kangasniemi, L., Nokisalmi, P., Dotti, G., Guse, K., Laasonen, L., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26216 · Cited by 99 · see citing works
Watanabe, T., Hioki, M., Fujiwara, T., Nishizaki, M., Kagawa, S., Taki, M., Kishimoto, H., Endo, Y., Urata, Y., Tanaka, N., et al. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.026 · Cited by 88 · see citing works
Self-citationEndo, Y., Sakai, R., Ouchi, M., Onimatsu, H., Hioki, M., Kagawa, S., Uno, F., Watanabe, Y., Urata, Y., Tanaka, N., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210884 · Cited by 87 · see citing works
Self-citationKuroda, S., Fujiwara, T., Shirakawa, Y., Yamasaki, Y., Yano, S., Uno, F., Tazawa, H., Hashimoto, Y., Watanabe, Y., Noma, K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2333 · Cited by 78 · see citing works
Self-citationRojas, J. J., Guedan, S., Searle, P. F., Martínez‐Quintanilla, J., Gil-Hoyos, R., Alcayaga‐Miranda, F., Cascalló, M., & Alemany, R. (2010) · Molecular Therapy · doi:10.1038/mt.2010.173 · Cited by 74 · see citing works
Fujiwara, T., Kagawa, S., Kishimoto, H., Endo, Y., Hioki, M., Ikeda, Y., Sakai, R., Urata, Y., Tanaka, N., & Fujiwara, T. (2006) · International Journal of Cancer · doi:10.1002/ijc.21846 · Cited by 73 · see citing works
Self-citationHashimoto, Y., Watanabe, Y., Shirakiya, Y., Uno, F., Kagawa, S., Kawamura, H., Nagai, K., Tanaka, N., Kumon, H., Urata, Y., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00665.x · Cited by 76 · see citing works
Self-citationYokoyama, T., Iwado, E., Kondo, Y., Aoki, H., Hayashi, Y., Georgescu, M. M., Sawaya, R. A., Hess, K. R., Mills, G. B., Kawamura, H., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.98 · Cited by 71 · see citing works
Self-citationCirculating tumor cells as a prognostic factor in patients with small cell lung cancer
Igawa, S., Gohda, K., Fukui, T., Ryuge, S., Otani, S., Masago, A., Sato, J., Murakami, K., Maki, S., Katono, K., et al. (2014) · Oncology Letters · doi:10.3892/ol.2014.1940 · Cited by 66 · see citing works
Development of oncolytic virotherapy: from genetic modification to combination therapy
Lan, Q., Xia, S., Wang, Q., Xu, W., Huang, H., Jiang, S., & Lu, L. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0750-4 · Cited by 66 · see citing works
The molecular pathogenesis of small cell lung cancer
D’Angelo, S. P., & Pietanza, M. C. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.1.12045 · Cited by 64 · see citing works
Oncolytic Virotherapy: Approaches to Tumor Targeting and Enhancing Antitumor Effects
Thorne, S. H., Hermiston, T. W., & Kirn, D. H. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.09.007 · Cited by 64 · see citing works
Kishimoto, H., Urata, Y., Tanaka, N., Fujiwara, T., & Hoffman, R. M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0556 · Cited by 64 · see citing works
Self-citationTelomeres and telomerase as targets for cancer therapy
Zimmermann, S., & Martens, U. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6481-8 · Cited by 62 · see citing works
Sasaki, T., Tazawa, H., Hasei, J., Kunisada, T., Yoshida, A., Hashimoto, Y., Yano, S., Yoshida, R., Uno, F., Kagawa, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2066 · Cited by 55 · see citing works
Self-citationLiu, D., Kojima, T., Ouchi, M., Kuroda, S., Watanabe, Y., Hashimoto, Y., Onimatsu, H., Urata, Y., & Fujiwara, T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0901 · Cited by 51 · see citing works
Self-citationTargeting homologous recombination-mediated DNA repair in cancer
Carvalho, J. F. S., & Kanaar, R. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.882900 · Cited by 46 · see citing works
Wang, Q., Ma, X., Wu, H., Zhao, C., Chen, J., Li, R., Yan, S., Li, Y., Zhang, Q., Song, K., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2096362 · Cited by 43 · see citing works
Sugio, K., Sakurai, F., Katayama, K., Tashiro, K., Matsui, H., Kawabata, K., Kawase, A., Iwaki, M., Hayakawa, T., Fujiwara, T., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2008 · Cited by 38 · see citing works
Self-citationAoyama, K., Kuroda, S., Morihiro, T., Kanaya, N., Kubota, T., Kakiuchi, Y., Kikuchi, S., Nishizaki, M., Kagawa, S., Tazawa, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14717-x · Cited by 38 · see citing works
Self-citationMajem, M., Cascalló, M., Bayó-Puxan, N., Mesı́a, R., Germà, J. R., & Alemany, R. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700940 · Cited by 38 · see citing works
Huang, P., Watanabe, M., Kaku, H., Kashiwakura, Y., Chen, J., Saika, T., Nasu, Y., Fujiwara, T., Urata, Y., & Kumon, H. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.3 · Cited by 37 · see citing works
Self-citationEnhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus
Tyler, M. A., Ulasov, I. V., Borovjagin, A. V., Sonabend, A. M., Khramtsov, A., Han, Y., Dent, P., Fisher, P. B., Curiel, D. T., & Lesniak, M. S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0187 · Cited by 37 · see citing works
New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
Chowaniec, H., Ślubowska, A., Mroczek, M., Borowczyk, M., Braszka, M., Dworacki, G., Dobosz, P., & Wichtowski, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1375433 · Cited by 36 · see citing works
Watanabe, Y., Kojima, T., Kagawa, S., Uno, F., Hashimoto, Y., Kyo, S., Mizuguchi, H., Tanaka, N., Kawamura, H., Ichimaru, D., et al. (2009) · Oncogene · doi:10.1038/onc.2009.415 · Cited by 33 · see citing works
Self-citationCurrent landscape and perspective of oncolytic viruses and their combination therapies
Su, Y., Su, C., & Qin, L. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101530 · Cited by 34 · see citing works
Kojima, T., Watanabe, Y., Hashimoto, Y., Kuroda, S., Yamasaki, Y., Yano, S., Ouchi, M., Tazawa, H., Uno, F., Kagawa, S., et al. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181deb69d · Cited by 33 · see citing works
Self-citationOncolytic virotherapy with modified adenoviruses and novel therapeutic targets
Halldén, G., & Portella, G. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.712962 · Cited by 30 · see citing works
Telomerase-Specific Virotheranostics for Human Head and Neck Cancer
Kurihara, Y., Watanabe, Y., Onimatsu, H., Kojima, T., Shirota, T., Hatori, M., Liu, D., Kyo, S., Mizuguchi, H., Urata, Y., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2690 · Cited by 30 · see citing works
Self-citationOncolytic virotherapy: the questions and the promise
Aurelian, L. (2013) · Oncolytic Virotherapy · doi:10.2147/ov.s39609 · Cited by 29 · see citing works
Hoffmann, D., & Wildner, O. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701055 · Cited by 28 · see citing works
Telomeres rather than telomerase a key target for anti‐cancer therapy?
Boukamp, P., & Mirancea, N. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00517.x · Cited by 27 · see citing works
Hasegawa, N., Abei, M., Yokoyama, K. K., Fukuda, K., Seo, E., Kawashima, R., Nakano, Y., Yamada, T., Nakade, K., Hamada, H., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28132 · Cited by 25 · see citing works
Efficient virotherapy for osteosarcoma by telomerase-specific oncolytic adenovirus
Li, G., Kawashima, H., Ogose, A., Ariizumi, T., Xu, Y., Hotta, T., Urata, Y., Fujiwara, T., & Endo, N. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0969-6 · Cited by 25 · see citing works
Self-citationMicroRNA-regulated transgene expression systems for gene therapy and virotherapy
Sakurai, F. (2011) · Frontiers in bioscience · doi:10.2741/3861 · Cited by 22 · see citing works
Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
Sakai, R., Kagawa, S., Yamasaki, Y., Kojima, T., Uno, F., Hashimoto, Y., Watanabe, Y., Urata, Y., Tanaka, N., & Fujiwara, T. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0205 · Cited by 24 · see citing works
Self-citationCervantes‐García, D., Ortı́z-López, R., Mayek-Pérez, N., & Rojas‐Martínez, A. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31885-x · Cited by 23 · see citing works
A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System
Ikeda, Y., Kojima, T., Kuroda, S., Endo, Y., Sakai, R., Hioki, M., Kishimoto, H., Uno, F., Kagawa, S., Watanabe, Y., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1763 · Cited by 23 · see citing works
Self-citationShen, Y.-H., Yang, F., Wang, H., Cai, Z., Xu, Y., Zhao, A., Su, Y., Zhang, G., & Zhu, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147173 · Cited by 19 · see citing works
MicroRNAs in brain metastases: big things come in small packages
McDermott, R., Gabikian, P., Sarvaiya, P. J., Ulasov, I. V., & Lesniak, M. S. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0971-3 · Cited by 17 · see citing works
Adenoviral Vectors for Prodrug Activation-based Gene Therapy for Cancer
Doloff, J. C., & Waxman, D. J. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990309 · Cited by 17 · see citing works
A novel molecular therapy using bioengineered adenovirus for human gastrointestinal cancer.
Fujiwara, T. (2011) · PubMed · doi:10.18926/amo/46626 · Cited by 17 · see citing works
Self-citationTelomerase-specific oncolytic virotherapy for human gastrointestinal cancer
Fujiwara, T., Shirakawa, Y., & Kagawa, S. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.200 · Cited by 16 · see citing works
Self-citationWang, H., Cai, Z., Yang, F., Luo, J., Satoh, M., Arai, Y., & Li, D. (2013) · Urology · doi:10.1016/j.urology.2013.10.025 · Cited by 15 · see citing works
Anti-tumor effects of telomelysin for head and neck squamous cell carcinoma
Fujita, F. (1994) · Oncology Reports · doi:10.3892/or_00000153 · Cited by 15 · see citing works
Sakakibara, A., Tsukuda, M., Kondo, N., Ishiguro, Y., Kimura, M., Fujita, K., Takahashi, H., & Matsuda, H. (2011) · Auris Nasus Larynx · doi:10.1016/j.anl.2011.01.018 · Cited by 12 · see citing works
Telomerase-specific virotherapy for human squamous cell carcinoma
Fujiwara, T. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590802715731 · Cited by 12 · see citing works
Self-citationOncolytic Adenoviruses in Gastrointestinal Cancers
Yokoda, R. T., Nagalo, B. M., & Borad, M. J. (2018) · Biomedicines · doi:10.3390/biomedicines6010033 · Cited by 10 · see citing works
Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agents
Fujiwara, T. (2007) · Frontiers in bioscience · doi:10.2741/2807 · Cited by 10 · see citing works
Self-citationSato, D., Kurihara, Y., Kondo, S., Shirota, T., Urata, Y., Fujiwara, T., & Shintani, S. (2013) · Oncology Reports · doi:10.3892/or.2013.2738 · Cited by 9 · see citing works
Self-citationOuchi, M., Kawamura, H., Urata, Y., & Fujiwara, T. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9169-5 · Cited by 8 · see citing works
Self-citationOncoselectivity in Oncolytic Viruses against Colorectal Cancer
Conrad, S. J., & Essani, K. (2014) · Journal of Cancer Therapy · doi:10.4236/jct.2014.513118 · Cited by 7 · see citing works
Highly efficient and carcinoma-specific adenoviral replication restricted by the EGP-2 promoter
Gommans, W. M., McLaughlin, P. M. J., Schalk, J. A. C., Groothuis, G. M. M., Haisma, H. J., & Rots, M. G. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.006 · Cited by 7 · see citing works
Controlling Adenoviral Replication to Induce Oncolytic Efficacy
Fillat, C. (2013) · The Open Gene Therapy Journal · doi:10.2174/1875037001003010015 · Cited by 5 · see citing works
Li, G., Kawashima, H., Ogose, A., Ariizumi, T., Hotta, T., Kuwano, R., Urata, Y., Fujiwara, T., & Endo, N. (2013) · Cancer Science · doi:10.1111/cas.12208 · Cited by 5 · see citing works
Self-citationRole of Telomeres and Telomerase in Cancer
Hiyama, K., Hiyama, E., Tanimoto, K., & Nishiyama, M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_7 · Cited by 4 · see citing works
Andreikos, D., Spandidos, D. A., & Georgakopoulou, V. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5729 · Cited by 3 · see citing works
Optimizing vector application for gene transfer into human hepatoblastoma cells
Warmann, S. W., Armeanu, S., Heitmann, H., Ruck, P., Seitz, G., Wessels, J. T., Lemken, M., Lauer, U. M., Fuchs, J., & Bitzer, M. (2006) · Pediatric Surgery International · doi:10.1007/s00383-006-1727-3 · Cited by 3 · see citing works
Development of Recombinant Adenovirus Carrying MicroRNA-regulated Gene Expression System
Sakurai, F., & Mizuguchi, H. (2010) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.130.1497 · Cited by 3 · see citing works
Self-citationUse of telomelysin (OBP-301) in mouse xenografts of human head and neck cancer
Kawakami (2009) · Oncology Reports · doi:10.3892/or_00000533 · Cited by 3 · see citing works
Targeted Oncolytic Adenovirus for Human Cancer Therapy: Gene-Based Therapies for Cancer
Fujiwara, T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6102-0_6 · Cited by 2 · see citing works
Self-citationKondo (2009) · Oncology Reports · doi:10.3892/or_00000643 · Cited by 16 · see citing works
Fujiwara, T., Urata, Y., & Tanaka, N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_13 · Cited by 2 · see citing works
Self-citationSasaki, T., Tazawa, H., Hasei, J., Kunisada, T., Yoshida, A., Hashimoto, Y., Yano, S., Yoshida, R., Uno, F., Kagawa, S., et al. (2012) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma.124.105 · Cited by 1 · see citing works
Self-citationReplication‐Selective Viruses for the Treatment of Cancer
Sampath, P., & Thorne, S. H. (2010) · doi:10.1002/9780470626528.ch6
Torras, S. P. (2007) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Exogenous and endogenous gene regulation for specific and efficient cancer gene therapy
Gommans, W. M. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Cancer Gene Therapy by Tissue‐specific and Cancer‐targeting Promoters
Hsu, J. L., Huo, L., Li, C., Hsu, Y.-H. E., Wang, Y., & Hung, M. (2014) · Wiley eBooks · doi:10.1002/9781118501665.ch5
Modification of regulatory and catalytic properties of phosphorylase-b by irradiation and heat.
Damjanovich, S., Csécsei, G., & Sümegi, J. (1971) · PubMed
Radiosensitization by telomerase-dependent oncolytic adenovirus
Kuroda, S., Fujiwara, T., Shirakawa, Y., Yamasaki, Y., Yano, S., Uno, F., Tazawa, H., Hashimoto, Y., Watanabe, Y., Noma, K., et al. (2011) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma.123.103
Self-citationIn Vivo Imaging of Human Cancer with Telomerase-Specific Replication-Selective Adenovirus
Fujiwara, T. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-797-2_9
Self-citationŠtagljar, I., & Snider, J. D. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1164525.626290
Sugio, K., Sakurai, F., Katayama, K., Tashiro, K., Matsui, H., Kawabata, K., Kawase, A., Iwaki, M., Hayakawa, T., Fujiwara, T., et al. (2023) · doi:10.1158/1078-0432.c.6519299.v1
Self-citationSugio, K., Sakurai, F., Katayama, K., Tashiro, K., Matsui, H., Kawabata, K., Kawase, A., Iwaki, M., Hayakawa, T., Fujiwara, T., et al. (2023) · doi:10.1158/1078-0432.c.6519299
Self-citationData from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
Sakai, R., Kagawa, S., Yamasaki, Y., Kojima, T., Uno, F., Hashimoto, Y., Watanabe, Y., Urata, Y., Tanaka, N., & Fujiwara, T. (2023) · doi:10.1158/1535-7163.c.6531678
Self-citationData from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
Sakai, R., Kagawa, S., Yamasaki, Y., Kojima, T., Uno, F., Hashimoto, Y., Watanabe, Y., Urata, Y., Tanaka, N., & Fujiwara, T. (2023) · doi:10.1158/1535-7163.c.6531678.v1
Self-citation
- Authors
- Taki, M., Kagawa, S., Nishizaki, M., Mizuguchi, H., Hayakawa, T., Kyo, S., Nagai, K., Urata, Y., Tanaka, N., & Fujiwara, T.
- Affiliations
- Okayama University (JP)
- National Institute of Health Sciences (JP)
- Kanazawa University (JP)
- Oncolys BioPharma (Japan) (JP)
- Corresponding author
- Fujiwara, Toshiyoshi
- Venue
- Oncogene
- Published
- 2005-02-21
- Volume
- 24
- Issue
- 19
- Pages
- 3130-3140
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2022386076
- Cited by
- 86
- References
- 27
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 4 · 2022: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2014: 5 · 2013: 6 · 2012: 4
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Physical Sciences › Environmental Science › Ecology › Bacteriophages and microbial interactions
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- oncolytic adenovirus, OBP-301, telomerase reverse transcriptase promoter, RGD motif, coxsackievirus and adenovirus receptor, lung cancer, colorectal cancer, glioblastoma, tumor xenografts, intratumoral injection, anticancer activity
- MeSH terms
- Adenoviridae, Animals, Cell Survival, Female, Flow Cytometry, Humans, Indicators and Reagents, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Neoplasms, Neoplasms, Experimental, Promoter Regions, Genetic, Receptors, Virus, Tetrazolium Salts, Time Factors, Tissue Distribution, Genetic Therapy, Treatment Outcome, Reverse Transcriptase Polymerase Chain Reaction, Amino Acid Motifs, Cell Line, Tumor, Green Fluorescent Proteins, Mice, Coxsackie and Adenovirus Receptor-Like Membrane Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
